IRIS

Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons?

Lasagna, Angioletta;Zuccaro, Valentina;Sacchi, Paolo;Bruno, Raffaele;Pedrazzoli, Paolo
2021-01-01
2021
The Oncology category covers resources on the etiology, prevention, diagnosis, and treatment of cancer such as chemotherapy, radiation and gene therapy. Cancer specialties such as gynecologic oncology, neuro-oncology, surgical oncology, radiological oncology, oral oncology and dermatological oncology are also included.
FUTURE ONCOLOGY
sì
WOS:000618355300001
2-s2.0-85103954580
Esperti anonimi
Inglese
Internazionale
17
13
1577
1580
4
33590770
Covalently closed circular DNA; OBI; Occult hepatitis B; cancer patients; immune checkpoint inhibitors; immunotherapy; prophylactic therapy; reactivation
6
info:eu-repo/semantics/article
262
Lasagna, Angioletta; Zuccaro, Valentina; Sacchi, Paolo; Chiellino, Silvia; Bruno, Raffaele; Pedrazzoli, Paolo
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1437875
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact